<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="73967">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02012543</url>
  </required_header>
  <id_info>
    <org_study_id>Agar jelly</org_study_id>
    <secondary_id>Kanten1</secondary_id>
    <nct_id>NCT02012543</nct_id>
  </id_info>
  <brief_title>Effect of Agar Administration on Defecation and Fecal Condition in Chronic Constipated Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Showa Inan General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Showa Inan General Hospital</source>
  <oversight_info>
    <authority>Japan: Ministry of Health, Labor and Welfare</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The administration of agar jelly may increase the number of defecation and the volume of
      feces, and then may improve fecal condition in chronic constipated patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Each subject eats one cap of agar jelly  shortly before having dinner every day for 4 weeks.

      At 0, 7th, 14th, 21th, and 28th day , the frequency of defecation and defecation condition
      is assessed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>the condition of feces</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Bristol scale is used.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the number and amount of defecation</measure>
    <time_frame>4 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>Agar jelly, constipation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects eat a cap of agar jelly (180g) shortly before eating dinner every day for 4 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Agar jelly</intervention_name>
    <arm_group_label>Agar jelly, constipation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  subjects take laxatives.

        Exclusion Criteria:

          -  subjects underwent abdominal surgery.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Akira Horiuchi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Showa Inan General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Akira Horiuchi, M.D.</last_name>
    <phone>81265822121</phone>
    <phone_ext>3012</phone_ext>
    <email>horiuchi.akira@sihp.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Showa Inan General Hospital</name>
      <address>
        <city>Komagane</city>
        <state>Nagano</state>
        <zip>399-4117</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Akira Horiuchi, MD</last_name>
      <phone>81265822121</phone>
      <phone_ext>3012</phone_ext>
      <email>horiuchi.akira@sihp.jp</email>
    </contact>
    <investigator>
      <last_name>Akira Horiuchi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 10, 2013</lastchanged_date>
  <firstreceived_date>November 9, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Showa Inan General Hospital</investigator_affiliation>
    <investigator_full_name>Akira Horiuchi</investigator_full_name>
    <investigator_title>Chief, Digestive Disease Center</investigator_title>
  </responsible_party>
  <keyword>constipation, agar</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
